Sarepta (SRPT) valued at unbelievable $11 BILLION and has still only one drug on Market .
--------
If former Chairman can repeat that what they did on SRPT then our Antisense has more than 10000% upside potential and even that would be wayyy lower than current valuation of SRPT . Its sad that this pure Goldmine is not listed on Nasdaq then this one would be valued north of $500 Million right now .
https://unauthorised investment advice/health/could-antisense-be-the-next-multi-billion-duchenne-muscular-dystrophy-biotech/
“I joined the board of Sarepta in 2007. We were in a very similar circumstance as Antisense,” he told *.
“We had a low market cap, we had low cash balance, we were fighting to get to the point where we could prove out our drug. Now look at what’s changed in the last 10 years. That’s what we’re trying to achieve at Antisense.”
- Forums
- ASX - By Stock
- DMD Phase 2 Results in Q4 = Potential 5000% Gem
Sarepta (SRPT) valued at unbelievable $11 BILLION and has still...
-
-
- There are more pages in this discussion • 259 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
0.002(2.50%) |
Mkt cap ! $73.92M |
Open | High | Low | Value | Volume |
8.1¢ | 8.5¢ | 8.1¢ | $145.4K | 1.739M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 69272 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 71037 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 69272 | 0.082 |
1 | 149432 | 0.081 |
2 | 127625 | 0.080 |
1 | 3600 | 0.079 |
2 | 250000 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 71037 | 1 |
0.086 | 480000 | 3 |
0.087 | 400000 | 1 |
0.088 | 417000 | 3 |
0.089 | 228000 | 3 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online